Skip to main content

Asuragen to Provide Ingenuity Systems IPA to Service Customers

NEW YORK, April 11 (GenomeWeb News) - Asuragen will provide the Ingenuity Pathway Analysis software to its molecular diagnostics service customers, Ingenuity Systems said today.

 

Asuragen, a spin-off from Ambion, will provide version 3.0 of the software for mRNA expression profiling to customers of its services business.

 

The company, comprised of Ambion's former diagnostics and services division as well as a discovery group, focuses on microRNAs as cancer diagnostics. Asuragen was formed after Applied Biosystems acquired Ambion's RNA business in March.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.